2. Academic Validation
  3. Modification of Metal-Organic Framework Nanoparticles Using Dental Pulp Mesenchymal Stem Cell Membranes to Target Oral Squamous Cell Carcinoma

Modification of Metal-Organic Framework Nanoparticles Using Dental Pulp Mesenchymal Stem Cell Membranes to Target Oral Squamous Cell Carcinoma

  • J Colloid Interface Sci. 2021 Nov:601:650-660. doi: 10.1016/j.jcis.2021.05.126.
Dabo Zhou 1,  Yixin Chen 2,  Wenhuan Bu 1,  Lin Meng 2,  Congcong Wang 2,  Nianqiang Jin 1,  Yumeng Chen 2,  Chunxia Ren 2,  Kai Zhang 3,  Hongchen Sun 4
Affiliations

Affiliations

  • 1 School and Hospital of Stomatology, China Medical University, 117 Nanjing North Street, Shenyang 110002, China.
  • 2 State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, 2699 Qianjin Street, Changchun 130012, China.
  • 3 State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, 2699 Qianjin Street, Changchun 130012, China. Electronic address: [email protected].
  • 4 School and Hospital of Stomatology, China Medical University, 117 Nanjing North Street, Shenyang 110002, China. Electronic address: [email protected].
PMID: 34091312 DOI: 10.1016/j.jcis.2021.05.126
Abstract

Engineering a targetable nanoparticle to tumor cell is a challenge issue for clinical application. Our results demonstrated that the chemokine CXCL8 secreted by oral squamous cell carcinoma (OSCC) could act as a chemoattractant to attract dental pulp mesenchymal stem cell (DPSC), which expressed the CXCL8 binding receptor, CXCR2, to the OSCC. Therefore, to create OSCC targetable nanoparticles, we used DPSC membranes to modify nanoparticles of metal-organic framework nanoparticles (MOFs) resulting in a novel MOF@DPSCM nanoparticle. Interestingly, results from in vitro and in vivo experiments illustrated that MOF@DPSCM possessed specificity for the OSCC, and the MOF@DPSCM carried DOX (doxorubicin), MOF-DOX@DPSCM could induce CAL27 cell death in vitro and block CAL27 tumor growth in vivo. Our data suggest that this novel MOF-DOX@DPSCM nanoparticle is a potential targetable drug delivery system for the OSCC in the future clinical application.

Keywords

Dental pulp mesenchymal stem cell; Metal-organic framework; Oral squamous cell carcinoma; Targetable nanoparticles or chemotherapy.

Figures
Products